Nanobiotix (NBTX) Payables (2019 - 2025)
Nanobiotix (NBTX) posted Payables of $10.6 million for Q4 2025, down 50.41% on a QoQ basis from $21.4 million in Q4 2024, and down 50.41% year-over-year from $21.4 million in Q4 2024.
Nanobiotix (NBTX) has 7 years of Payables data on file, last reported at $10.6 million in Q4 2025.
- In Q4 2025, Payables fell 50.41% year-over-year to $10.6 million; the TTM figure through Dec 2025 stood at $10.6 million (down 50.41% YoY), while the FY2025 annual figure was $10.3 million, down 52.48% from the prior year.
- Payables declined to $10.6 million in Q4 2025, from $21.4 million in the prior quarter.
- Across five years, Payables topped out at $21.4 million in Q4 2024 and bottomed at $7.4 million in Q4 2021.
- A 5-year average of $13.8 million and a median of $10.6 million in 2025 frame the typical range for Payables.
- Annual changes were most pronounced in 2023 — Payables surged 99.9% — and 2025, when it sank 50.41%.
- Year by year, Payables stood at $7.4 million in 2021, then jumped by 32.37% to $9.8 million in 2022, then jumped by 99.9% to $19.6 million in 2023, then rose by 9.11% to $21.4 million in 2024, then sank by 50.41% to $10.6 million in 2025.
- The last three Payables figures came in at $10.6 million (Q4 2025), $21.4 million (Q4 2024), and $19.6 million (Q4 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 300,549.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 1.05 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 83.00 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 10.62 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 8.69 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 489.30 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 1.03 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 126.63 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | 80.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 10.62 Mn |
| Jun 30, 2025 | 13.17 Mn |
| Dec 31, 2024 | 21.41 Mn |
| Jun 30, 2024 | 20.61 Mn |
| Dec 31, 2023 | 19.62 Mn |
| Jun 30, 2023 | 18.20 Mn |
| Dec 31, 2022 | 9.82 Mn |
| Jun 30, 2022 | 9.86 Mn |
| Dec 31, 2021 | 7.42 Mn |
| Jun 30, 2021 | 10.61 Mn |
| Dec 31, 2020 | 8.47 Mn |
| Dec 31, 2019 | 8.60 Mn |